Linked Life Data

11884927

Source:http://linkedlifedata.com/resource/pubmed/id/11884927

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2002-3-8
pubmed:abstractText
Although recent experimental studies have demonstrated CTLA4Ig to be a potent immunosuppressant in vascularized solid organ allografts, little attention has been given to the effect of this soluble recombinant fusion protein on immunosuppression in composite tissue allografts (CTAs). Using a rat hind limb allograft model, we examined the efficacy of CTLA4Ig against the allograft rejection of composite tissue.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0041-1337
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
73
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
334-40
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Feasibility of immunosuppression in composite tissue allografts by systemic administration of CTLA4Ig.
pubmed:affiliation
Department of Orthopaedic Surgery, Hokkaido University School of Medicine, Hokkaido University, Sapporo 060-8638, Japan. niwasaki@med.hokudai.ac.jp.
pubmed:publicationType
Journal Article